MRA Launches “Fight Back Give Back” Campaign to Highlight Importance of Clinical Trials in Patient Care and Research Process

The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, today launches its nationwide “Fight Back Give Back” campaign to highlight the importance of clinical trials in driving progress towards curing disease. “Too many patients never consider participating in clinical trials or else too often wait until they have few if any other options,” said MRA President and CEO Michael Kaplan. “However, for many patients, clinical trials represent the best way to get access to new, potentially better treatments. We believe that until you’ve considered clinical trials, you…

Read More